FIBROBIOLOGICS INC (FBLG) Stock Balance Sheet
NASDAQ:FBLG - US31573L1052 - Common Stock
0.5901 USD
-0.03 (-4.85%)
0.591 USD
+0 (+0.15%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 8.85M | 13.98M | 9.16M | 2.27M | 407.00K | |||
| Receivables | N/A | N/A | 0.00 | 300.00K | N/A | |||
| Other Current Assets | 1.33M | 243.00K | 52.00K | 59.00K | 61.00K | |||
| Total Current Assets | 10.18M | 14.23M | 9.21M | 2.63M | 468.00K | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.68M | 2.22M | 2.61M | 2.20M | N/A | |||
| Other Non-Current Assets | 48.00K | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 3.73M | 2.22M | 2.61M | 2.20M | 0.00 | |||
| TOTAL ASSETS | 13.91M | 16.45M | 11.82M | 4.82M | 468.00K | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 8.07M | 9.17M | 141.00K | 5.45M | 1.52M | |||
| Accrued Expenses | 627.00K | 401.00K | 362.00K | 326.00K | N/A | |||
| Accounts Payable | 1.80M | 2.70M | 1.44M | 758.00K | 233.00K | |||
| Other Current Liabilities | 470.00K | 460.00K | 7.24M | 538.00K | N/A | |||
| Total Current Liabilities | 10.96M | 12.73M | 9.18M | 7.07M | 1.76M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 2.08M | 984.00K | 1.39M | 1.75M | N/A | |||
| Total Non-Current Liabilities | 2.08M | 984.00K | 1.39M | 1.75M | 0.00 | |||
| TOTAL LIABILITIES | 13.05M | 13.71M | 10.57M | 8.82M | 1.76M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -45.14M | -35.52M | -24.36M | -7.87M | -2.75M | |||
| Additional Paid In Capital | 46.00M | 38.25M | 25.61M | 2.41M | N/A | |||
| Common Shares | 400.00 | 400.00 | 1.00K | 1.46M | 1.46M | |||
| Other Shareholders' Equity | -400.00 | -400.00 | N/A | N/A | N/A | |||
| Shares Outstanding | 40.86M | 35.09M | 32.63M | 32.48M | 32.48M | |||
| Tangible Book Value per Share | 0.02 | 0.08 | 0.04 | -0.17 | -0.08 | |||
| Total Shareholders' Equity | 860.00K | 2.73M | 1.25M | -4.00M | -1.29M | |||
| TOTAL LIABILITIES AND EQUITY | 13.91M | 16.45M | 11.82M | 4.82M | 468.00K | |||
| Statistics | ||||||||
| Current Ratio | 0.93 | 1.12 | 1.00 | 0.37 | 0.27 | |||
| Return On Assets (ROA) | -95.08% | -67.87% | -161.22% | -106.16% | -338.03% | |||
| Return On Equity (ROE) | -1537.56% | -408.08% | -1520.99% | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21